CIBC Private Wealth Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100
Closed -$1K 1046
2022
Q2
$1K Hold
100
﹤0.01% 1171
2022
Q1
$2K Buy
+100
New +$2.56K ﹤0.01% 1222

Other funds holding NBP

CIBC Private Wealth Group's NBP Position: Q3 2022 in Review

CIBC Private Wealth Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 100 shares — an estimated $1K sold.

CIBC Private Wealth Group first reported a position in NBP in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • CIBC Private Wealth Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • CIBC Private Wealth Group sold 100 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $1K.
  • CIBC Private Wealth Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2022 and held it in 2 quarters.
  • CIBC Private Wealth Group's NovaBridge Biosciences American Depositary Shares position peaked at $2K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on CIBC Private Wealth Group's 13F filing for Q3 2022, filed 15 Nov 2022.